| Customization: | Available |
|---|---|
| Powder: | Yes |
| Customized: | Customized |
|
Still deciding? Get samples of US$ 280/kg
Request Sample
|
Suppliers with verified business licenses
Audited Supplier Audited by an independent third-party inspection agency
Eltrombopag is sold under the trade name Promacta and includes a drug used to treat thrombocytopenia and severe aplastic anemia. Promacta is called Revolade outside of the United States and is sold worldwide by Novartis. It is a thrombopoietin receptor agonist.
Function of Eltrombopag
1. It is used for low platelet levels and aplastic anemia at the same time
2. Chronic immune thrombocytopenia
3. Chronic hepatitis C related thrombocytopenia
Application of Eltrombopag
Eltrombopag is sold under the trade name Promacta and includes a drug used to treat thrombocytopenia and severe aplastic anemia. Promacta is called Revolade outside of the United States and is sold worldwide by Novartis. It is a thrombopoietin receptor agonist.
| Item | Test Standard | Testing Result | |
| Assay | 99% | Complies | |
| Apperence | Red Powder | Complies | |
| Particle Size | 100% pass 80 mesh | Complies | |
| Oder | Characteristic | Complies | |
| Taste | Characteristic | Complies | |
| Loss on Drying | ≤5.0% | 2.20% | |
| Residue on Ignition | ≤0.1% | 0.05% | |
| Residual | ≤0.1% | Complies | |
| Residual Ethanol | ≤0.5% | Complies | |
| Heave Mentals | ≤10ppm | Complies | |
| Na | ≤0.1% | <0.1% | |
| Pb | ≤3 ppm | Complies | |
| Total Plate | <1000CFU/g | Complies | |
| Yeast & Mold | <100 CFU /g | Complies | |
| E. Coli | Negative | Complies | |
| Salmonella | Negative | Complies | |
){kind=link}